Received Jun 30, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | 39H2S | — |
administered only the adjuvant portion of Shingrix; administered only the adjuvant portion of Shingrix; This non-serious case was reported by a nurse via call center representative and described the occurrence of inappropriate preparation of medication in a 71-year-old male patient who received Herpes zoster (Shingrix) (batch number 39H2S, expiry date 31-MAR-2027) for prophylaxis. On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced inappropriate preparation of medication (Verbatim: administered only the adjuvant portion of Shingrix) and inappropriate dose of vaccine administered (Verbatim: administered only the adjuvant portion of Shingrix). The outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were not applicable. Additional Information: GSK Receipt Date: 18-JUN-2025 Nurse called to report that they accidentally could have administered only the adjuvant portion of Shingrix to patient. Also stated that this would be the first dose of Shingrix for the patient and asked is there any immunity screening or any titers test for Shingrix. Asked if they have to revaccinate the patient involved in this possible administration of the adjuvant only. The patient received only adjuvant of Shingrix, which led to inappropriate preparation of medication and inappropriate dose of vaccine administered. This is one of the seven linked cases, reported by the same reporter.; Sender's Comments: US-GSK-US2025076585:Same reporter/Diffrent patient US-GSK-US2025076589:Same reporter/Diffrent patient US-GSK-US2025076586:Same reporter/Diffrent patient US-GSK-US2025076593:Same reporter/Diffrent patient US-GSK-US2025076594:Same reporter/Diffrent patient US-GSK-US2025076598:Same reporter/Diffrent patient